共 381 条
[1]
Dohner H(2015)Acute myeloid leukemia N Engl J Med 373 1136-1152
[2]
Weisdorf DJ(2015)Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT Haematologica 100 859-869
[3]
Bloomfield CD(2014)Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution’s three decade experience Biol Blood Marrow Transplant 20 1217-1223
[4]
Sengsayadeth S(2011)Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria Blood 117 3214-3219
[5]
Savani BN(2012)Peripheral-blood stem cells versus bone marrow from unrelated donors N Engl J Med 367 1487-1496
[6]
Blaise D(2015)Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research Biol Blood Marrow Transplant 21 266-274
[7]
Malard F(2001)Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO) Blood 98 2942-2947
[8]
Nagler A(2009)Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial Lancet Oncol 10 855-864
[9]
Mohty M(2016)Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial Lancet Oncol 17 164-173
[10]
Malard F(2016)Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Engl J Med 374 43-53